DK0980254T3 - Farmaceutisk antiviruspræparat omfattende glycyrrhizinsyre og mindst et protein udstyret med antiviral aktivitet - Google Patents

Farmaceutisk antiviruspræparat omfattende glycyrrhizinsyre og mindst et protein udstyret med antiviral aktivitet

Info

Publication number
DK0980254T3
DK0980254T3 DK98925588T DK98925588T DK0980254T3 DK 0980254 T3 DK0980254 T3 DK 0980254T3 DK 98925588 T DK98925588 T DK 98925588T DK 98925588 T DK98925588 T DK 98925588T DK 0980254 T3 DK0980254 T3 DK 0980254T3
Authority
DK
Denmark
Prior art keywords
antivirus
pharmaceutical
preparation
antiviral activity
glycyrrhizinic acid
Prior art date
Application number
DK98925588T
Other languages
Danish (da)
English (en)
Inventor
Raffaello Pompei
Mario Pinza
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Application granted granted Critical
Publication of DK0980254T3 publication Critical patent/DK0980254T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK98925588T 1997-05-14 1998-05-06 Farmaceutisk antiviruspræparat omfattende glycyrrhizinsyre og mindst et protein udstyret med antiviral aktivitet DK0980254T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI001119A IT1291366B1 (it) 1997-05-14 1997-05-14 Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale
PCT/EP1998/002797 WO1998051334A1 (en) 1997-05-14 1998-05-06 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity

Publications (1)

Publication Number Publication Date
DK0980254T3 true DK0980254T3 (da) 2002-05-06

Family

ID=11377123

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98925588T DK0980254T3 (da) 1997-05-14 1998-05-06 Farmaceutisk antiviruspræparat omfattende glycyrrhizinsyre og mindst et protein udstyret med antiviral aktivitet

Country Status (26)

Country Link
US (1) US6329339B1 (enExample)
EP (1) EP0980254B1 (enExample)
JP (2) JP2001525814A (enExample)
KR (1) KR100592193B1 (enExample)
CN (1) CN1114447C (enExample)
AR (1) AR012849A1 (enExample)
AT (1) ATE212232T1 (enExample)
AU (1) AU740944B2 (enExample)
BG (1) BG64748B1 (enExample)
CA (1) CA2289550A1 (enExample)
CZ (1) CZ291932B6 (enExample)
DE (1) DE69803565T2 (enExample)
DK (1) DK0980254T3 (enExample)
EA (1) EA003126B1 (enExample)
ES (1) ES2170501T3 (enExample)
GE (1) GEP20022672B (enExample)
HU (1) HU224956B1 (enExample)
IL (2) IL132651A0 (enExample)
IT (1) IT1291366B1 (enExample)
PL (1) PL189218B1 (enExample)
PT (1) PT980254E (enExample)
SK (1) SK283584B6 (enExample)
TR (1) TR199902730T2 (enExample)
UA (1) UA63955C2 (enExample)
WO (1) WO1998051334A1 (enExample)
ZA (1) ZA983917B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7151082B2 (en) * 1999-02-11 2006-12-19 The Feinstein Institute For Medical Research Antagonists of HMG1 for treating inflammatory conditions
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US7304034B2 (en) * 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
EP1499341A4 (en) * 2002-04-18 2010-10-27 Univ Iowa Res Found METHOD FOR INHIBITING AND TREATING BACTERIAL BIOFILMS WITH METAL CHELATE IMAGES
US7696169B2 (en) * 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
AU2004272607B2 (en) * 2003-09-11 2008-11-06 Cornerstone Therapeutics Inc. Monoclonal antibodies against HMGB1
WO2007011606A2 (en) * 2005-07-18 2007-01-25 Critical Therapeutics, Inc. USE OF HMGBl ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS
US20080311122A1 (en) * 2005-11-28 2008-12-18 Medimmune, Llc Antagonists of Hmgb1 and/or Rage and Methods of Use Thereof
IT1391170B1 (it) * 2008-08-07 2011-11-18 D M G Italia S R L Composizione topica intra-nasale utilizzabile in caso di ostruzione nasale
CA2809031C (en) * 2010-08-25 2018-10-16 Weijian Zhang Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
US9416151B2 (en) 2010-08-25 2016-08-16 Lurong ZHANG Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
CN106029089B (zh) * 2014-02-21 2020-12-29 丘比株式会社 诺如病毒灭活剂及其制造方法
US12594285B2 (en) 2016-02-25 2026-04-07 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
EP3419629A4 (en) * 2016-02-25 2019-10-30 Applied Biological Laboratories, Inc. COMPOSITIONS AND PROCEDURES FOR PROTECTION AGAINST AIRBORNE PATHOGENES AND IRRITATES
US12447166B2 (en) 2016-02-25 2025-10-21 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
CN109022351B (zh) * 2018-09-28 2021-10-19 广州奇龙生物科技有限公司 重组人溶菌酶的新应用
CN112135625B (zh) * 2020-04-27 2021-07-06 广州新创忆药物临床研究有限公司 一种预防或治疗covid-19新冠肺炎的药物及其应用
MX2021005280A (es) * 2021-05-04 2022-02-23 Spv Timser S A P I De C V Composicion farmaceutica que contiene triterpenoides pentaciclicos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085800B2 (ja) * 1986-12-19 1996-01-24 エーザイ株式会社 塩化リゾチ−ム及びグリチルリチン酸ジカリウム含有水溶液製剤
JP2838720B2 (ja) * 1989-10-31 1998-12-16 ゼリア新薬工業株式会社 安定な点眼剤
JP4056099B2 (ja) * 1996-05-09 2008-03-05 森永乳業株式会社 水生動物の寄生生物性疾患の予防および治療剤

Also Published As

Publication number Publication date
ZA983917B (en) 1998-11-09
TR199902730T2 (xx) 2000-02-21
EA003126B1 (ru) 2003-02-27
HUP0002985A3 (en) 2001-04-28
JP2009102370A (ja) 2009-05-14
CN1114447C (zh) 2003-07-16
CZ399199A3 (cs) 2000-04-12
AR012849A1 (es) 2000-11-22
GEP20022672B (en) 2002-04-25
CZ291932B6 (cs) 2003-06-18
IT1291366B1 (it) 1999-01-07
PL336802A1 (en) 2000-07-17
SK283584B6 (sk) 2003-10-07
KR20010012419A (ko) 2001-02-15
KR100592193B1 (ko) 2006-06-23
US6329339B1 (en) 2001-12-11
IL132651A (en) 2006-10-31
CA2289550A1 (en) 1998-11-19
ES2170501T3 (es) 2002-08-01
EP0980254A1 (en) 2000-02-23
HU224956B1 (en) 2006-04-28
UA63955C2 (uk) 2004-02-16
WO1998051334A1 (en) 1998-11-19
IL132651A0 (en) 2001-03-19
DE69803565T2 (de) 2002-08-08
PT980254E (pt) 2002-07-31
PL189218B1 (pl) 2005-07-29
HUP0002985A2 (hu) 2001-01-29
AU740944B2 (en) 2001-11-15
AU7764698A (en) 1998-12-08
CN1255859A (zh) 2000-06-07
ITMI971119A1 (it) 1998-11-14
BG103968A (en) 2000-07-31
HK1028347A1 (en) 2001-02-16
EA199901024A1 (ru) 2000-06-26
ITMI971119A0 (enExample) 1997-05-14
BG64748B1 (bg) 2006-02-28
DE69803565D1 (de) 2002-03-14
JP2001525814A (ja) 2001-12-11
EP0980254B1 (en) 2002-01-23
SK154499A3 (en) 2000-08-14
ATE212232T1 (de) 2002-02-15

Similar Documents

Publication Publication Date Title
PT869126E (pt) Derivados de ditiolano, sua preparacao e seus efeitos terapeuticos
PT911340E (pt) Isoquinolinas-3-carboxamidas substituidas, sua preparacao e utilizacao como farmacos
NO994438D0 (no) Terapeutisk aktive diarylpropylaminer samt fremstilling og anvendelse derav
NO993315D0 (no) Raskt frigjörende og smaksmaskerende farmasöytisk doseringsform
PT1032555E (pt) Aminoacidos ciclicos e derivados uteis como agentes farmaceuticos
ITMI982280A0 (it) Alcune n-(2-april-propionil)-solfonammidi e preparazioni farmaceutiche che le contengono
EE05000B1 (et) 2'-asendatud 1,1'-bifenüül-2-karboksamiidid, nende kasutamine ja farmatseutilised preparaadid
NO20015665D0 (no) Substituerte fenylforbindelser med immunsuppresjonsaktivitet og farmasöytiske preparater
MA24573A1 (fr) Derives de l'acide barbiturique avec une activite anti-metastasique et anti-tumorale
ATE288419T1 (de) Alpha-aryl-n-alkylnitrone sowie diese enthaltende pharmazeutische zubereitungen
FI943512L (fi) Ihmisen seerumialbumiini, valmistus ja käyttö
IT1291366B1 (it) Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale
IT1291353B1 (it) Peptidi con attivita' antivirale
PT878467E (pt) Acidos 6-aminotetra-hidroisoquinolinacarboxilicos e 7-aminotetra-hidroisoquinolinacarboxilicos substituidos
DK0984788T3 (da) Farmaceutiske præparater af peptider med lav opløselighed i fysiologiske medier
EP0711310A4 (en) Human antibodies against varicella-zoster virus
IT8667408A0 (it) Preparati farmaceutici ad effetto antiipertensivo e cardioprotettivo
DE69837507D1 (de) Humanes Hedgehog-Protein
NO20000066D0 (no) 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasoeytiske anvendelse
EE200200353A (et) Inimese heparanaasisarnane polüpeptiid ja nukleiinhape
DE3674017D1 (de) Oxalursaeure-derivate und pharmazeutisches mittel.
DE69919860D1 (de) 2-methylpropionsäure-derivate und sie enthaltende medizinische zubereitungen
DE69802131D1 (de) Humane Protein-Kinase hYAK3
FI963316L (fi) Hiilihapon diesterit, joilla on viruksia torjuvaa ja tulehdusta torjuvaa aktiivisuutta
DK1216021T3 (da) Farmaceutiske og/eller kosmetiske præparater